SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.173+1.5%Dec 17 3:27 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john view who wrote (329)4/3/1997 10:21:00 AM
From: Antonios Petropoulos   of 1605
 
John, I actually heard the presentation last night.
The CEO I think was honest enough and he did mention that the quarterly revenues that will be announced will NOT be good,and probable worse than last time. But that is not to worry us,since we know that studies are still in progress and therefore no 'real' revenue can be generated. That is what one of his main points were.
He did mention though that once the studies are complete and the insurance companies start paying then revenues will flow.

I agree that if the studies are indeed positive,as everything indicates until now, then revenues will NOT be a problem. We just have to be patient for a few months until those results come out.
Then I think Vaso will reach again $4.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News